Severe hypertriglyceridemia (hyperchylomicronemia), an actual challenge in daily clinic

Yentl de Roeck^{1

2}, Marcel Th B Twickler^{3

4}

Affiliations

¹ Department of Endocrinology and Diabetology, ZNA Middelheim Hospital, Antwerp, Belgium.
² Department of Endocrinology, Diabetology and Metabolic Disease, Antwerp University Hospital, Edegem, Belgium.
³ Department of Endocrinology, Diabetology and Metabolic Disease, AZ Monica, Deurne, Antwerp, Belgium.
⁴ Faculty of Medicine and Health Sciences, Antwerp University, Antwerp, Belgium.

Editorial

Yentl de Roeck et al. Eur J Clin Invest. 2020 Nov.

. 2020 Nov;50(11):e13399.

doi: 10.1111/eci.13399. Epub 2020 Sep 27.

Yentl de Roeck^{1

2}, Marcel Th B Twickler^{3

4}

¹ Department of Endocrinology and Diabetology, ZNA Middelheim Hospital, Antwerp, Belgium.
² Department of Endocrinology, Diabetology and Metabolic Disease, Antwerp University Hospital, Edegem, Belgium.
³ Department of Endocrinology, Diabetology and Metabolic Disease, AZ Monica, Deurne, Antwerp, Belgium.
⁴ Faculty of Medicine and Health Sciences, Antwerp University, Antwerp, Belgium.

No abstract available

Comment on

Evaluation of the chylomicron-TG to VLDL-TG ratio for type I hyperlipoproteinemia diagnostic.
Rioja J, Ariza MJ, García-Casares N, Coca-Prieto I, Arrobas T, Muñiz-Grijalvo O, Mangas A, Ibarretxe D, Sánchez-Chaparro MÁ, Valdivielso P. Rioja J, et al. Eur J Clin Invest. 2020 Dec;50(12):e13345. doi: 10.1111/eci.13345. Epub 2020 Aug 11. Eur J Clin Invest. 2020. PMID: 32649781

1. Laufs U, Parhofer KG, Ginsberg HN, Hegele RA. Clinical review on triglycerides. Eur Heart J. 2020;41(1):99-109.
1. Chait A, Eckel RH. The chylomicronemia syndrome is most often multifactorial: a narrative review of causes and treatment. Ann Intern Med. 2019;170:626.
1. Pradhan AD. A new beginning for triglyceride-lowering therapies. Circulation. 2019;140:167-169.